Xencor | XNCR - Capital De Empréstimo





Capital De Empréstimo Alterar Data
AbbVie USD 64.53B 5.59B 2026-03
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Amgen USD 51.86B 27M 2026-06
Arrowhead Research USD 824.07M 401.34M 2026-06
AstraZeneca USD 26.01B 46M 2026-06
Biogen USD 7.29B 1B 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Cytokinetics USD 248.2M 993K 2026-06
GlaxoSmithKline GBP 13.95B 65M 2026-06
J&J USD 37.34B 183M 2026-06
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
MacroGenics USD 68.71M 1.29M 2026-03
Merck USD 51.08B 4.41B 2026-06
Novartis USD 37.49B 42M 2026-06
Pfizer USD 60.5B 70M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Xencor USD 77.54M 4.59M 2026-06